slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 21,541-21,570
Pages 1,935
Rows per page 30
Slide function
21,541-21,570 of 58,039
08
Includes clinical trial data (101A/102A) for Arginase 1 Deficiency.Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · NeedLoop · Pattern Hunter1 hit
09
The chart shows exponential growth in annual shipments, with the final bar representing 22.8 billion units in 2019.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
10
The slide uses a waterfall chart to show license accumulation and a stacked area chart to show revenue contribution by license vintage.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
17
The chart uses a dual-axis approach to correlate financial metrics with headcount growth.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations Beat · Financials1 hit
14
CADSS = Clinician Administered Dissociative States Scale. Data points are plotted over time (Baseline, 15m, 40m, 90m).ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
37
The slide highlights margin expansion and cost management strategies.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
38
Includes explanatory callouts for performance drivers and a disclaimer regarding the preliminary nature of the data.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
39
Includes a table showing pre-IPO and post-IPO pro forma debt levels and credit statistics.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
43
Contains four distinct financial reconciliation tables with detailed footnotes.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
13
The slide presents clinical trial safety data comparing Placebo, Nefecon 16mg, and Nefecon 8mg.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Product1 hit
14
Data presented as box plots comparing End of Treatment (EoT) and Last follow-up.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
15
Data derived from post-hoc analyses. HbA1c is a measure of diabetes risk.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
23
The slide presents findings from both qualitative interviews and a quantitative survey to validate market demand.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
25
The network diagram illustrates the connectivity between KOLs (orange) and the broader nephrologist community (blue).Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
34
The chart demonstrates a strong correlation (R^2=0.90) between proteinuria reduction and ESRD risk reduction, supporting the use of proteinuria as a surrogate endpoint.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
35
The table shows percentage changes or values for various renal markers. The 16mg dose consistently shows stronger efficacy (higher percentage reductions in protein/albumin) compared to 8mg.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
07
Includes logos of portfolio companies: DEPT, Sequent, MAK-SYSTEM, Adams Outdoor Advertising.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
16
Includes data for 2016-2020. Financial metrics are in $mm, AUM in $bn.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
17
Includes data for Total AUM, Fee-Earning AUM, and financial performance metrics (FRE, Net Realized Performance Revenues, Distributable Earnings).Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
18
Carlyle | Investor Conference Presentation Deck | 26 slidesCarlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
20
Includes footnotes regarding dividend policy and share eligibility.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Evidence1 hit
21
Includes footnotes regarding specific adjustments and accounting periods.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Evidence1 hit
13
The slide breaks down operating expenses into three categories, showing 1Q19 vs 1Q20 comparisons, with an adjustment for SG&A.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations 1 hit
28
The slide uses three distinct bar charts to illustrate growth in key performance metrics.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · Action1 hit
29
The slide uses three distinct bar charts to illustrate expense trends, with specific callouts explaining the 2019 performance for each category.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · Action1 hit
30
The slide demonstrates that inventory remains very low relative to GMV and Revenue, supporting the 'Capital Efficient' claim.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · Action1 hit
32
The slide provides a detailed breakdown of unit economics, specifically highlighting the improvement in contribution margin.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · Action1 hit
38
Standard financial reconciliation table found in an appendix.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations 1 hit
39
The table shows adjustments for non-cash items like depreciation, amortization, and stock-based compensation, as well as one-time items like legal settlements and donations.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations 1 hit
40
Data is in millions of dollars.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations 1 hit